Association of creatine kinase and skin toxicity in phase I trials of anticancer agents von Moreno Garcia, V, Thavasu, P, Blanco Codesido, M, Molife, L R, Vitfell Pedersen, J, Puglisi, M, Basu, B, Shah, K, Iqbal, J, de Bono, J S, Kaye, S B, Banerji, U

Volltext

1202 ORAL A Phase I Study of the Potent AKT Inhibitor MK-2206 in Combination With Carboplatin and Paclitaxel, Docetaxel or Erlotinib in Patients With Advanced Solid Tumours von Molife, L.R, Minton, S, Vitfell-Pedersen, J, Chen, E, Sullivan, D, Yan, L, Zernhelt, A.M, Siu, L, de Bono, J.S, Tolcher, A.W

Volltext

1232 POSTER Creatinine Clearance (CrCI) as a Predictive Marker for the Risk of Toxicity From Molecularly Targeted Agents (MTA) in Phase I Trials von Vitfell-Pedersen, J, Basu, B, Moreno, V, Tjokrowidjaja, A, Puglisi, M, Shah, K, Malvankar, S, Alam, S, Molife, R, Banerji, U

Volltext

Creatinine Clearance Is Associated with Toxicity from Molecularly Targeted Agents in Phase I Trials von Basu, B., Vitfell-Pedersen, J., Moreno Garcia, V., Puglisi, M., Tjokrowidjaja, A., Shah, K., Malvankar, S., Anghan, B., de Bono, J.S., Kaye, S.B., Molife, L.R., Banerji, U.

Volltext

The role of surgery in patients with advanced gynaecological cancers participating in phase I clinical trials von Vitfell-Pedersen, J, Yap, T A, Moreno, V, Baird, R D, Khan, A Z, Barton, D P J, Kaye, S B

Volltext

45 Preliminary results of a phase 1 study of intravenous administration of GL-ONC1 vaccinia virus including green-fluorescent protein real time imaging in patients with advanced ca... von Vitfell-Pedersen, J, Karapanagiotou, E.M, Alam, S, Puglisi, M, Britton, L, Sassi, S, Mansfield, D, Yap, T, De-Bono, J, Harrington, K

Volltext

Association of creatine kinase and skin toxicity in phase I trials of anticancer agents von Moreno Garcia, V, Thavasu, P, Blanco Codesido, M, Molife, LR, Vitfell Pedersen, J, Puglisi, M, Basu, B, Shah, K, Iqbal, J, de Bono, JS, Kaye, SB, Banerji, U

Volltext bestellen